Butyrylcholinesterase: a target in the cholinergic treatment of Alzheimer's disease

ISSN： 1473-4885

Source： Primary Care Psychiatry, Vol.9, Iss.3, 2004-09, pp. : 83-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease

Current Alzheimer Research, Vol. 13, Iss. 10, 2016-08 ,pp. : 1173-1177

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer Disease—No Target for Statin Treatment. A Mini Review

By Hoyer Siegfried Riederer Peter

Neurochemical Research, Vol. 32, Iss. 4-5, 2007-04 ,pp. : 695-706

Springer Publishing Company

Access to resources Recommend Favorite

Selective Acetyl- and Butyrylcholinesterase Inhibitors Reduce Amyloid-β Ex Vivo Activation of Peripheral Chemo-cytokines From Alzheimer's Disease Subjects: Exploring the Cholinergic Anti-inflammatory Pathway

Current Alzheimer Research, Vol. 11, Iss. 6, 2014-07 ,pp. : 608-622

Bentham Science Publishers

Access to resources Recommend Favorite

Cdk5 as a Drug Target for the Treatment of Alzheimer’s Disease

By Lau Lit-Fui Seymour Patricia A. Sanner Mark A. Schachter Joel B.

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 267-274

Humana Press, Inc

Access to resources Recommend Favorite

Cellular Stress Reactions as Putative Cholinergic Links in Alzheimer’s Disease

By Toiber Debra Soreq Hermona

Neurochemical Research, Vol. 30, Iss. 6-7, 2005-06 ,pp. : 909-919

Springer Publishing Company

Access to resources Recommend Favorite